Scatena, Roberto
 Distribuzione geografica
Continente #
EU - Europa 2.456
NA - Nord America 2.160
AS - Asia 660
AF - Africa 11
SA - Sud America 7
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 5.301
Nazione #
US - Stati Uniti d'America 2.141
DE - Germania 550
RU - Federazione Russa 517
CN - Cina 394
SE - Svezia 363
UA - Ucraina 311
IT - Italia 150
PL - Polonia 143
IE - Irlanda 114
TR - Turchia 92
FR - Francia 86
FI - Finlandia 78
SG - Singapore 68
GB - Regno Unito 59
IN - India 48
BE - Belgio 18
ES - Italia 17
CA - Canada 16
JP - Giappone 14
NL - Olanda 14
KR - Corea 12
RO - Romania 9
CH - Svizzera 7
HK - Hong Kong 6
IR - Iran 6
CZ - Repubblica Ceca 5
ID - Indonesia 5
MA - Marocco 5
VN - Vietnam 5
AU - Australia 3
BR - Brasile 3
BY - Bielorussia 3
CO - Colombia 3
IQ - Iraq 3
MX - Messico 3
TW - Taiwan 3
BG - Bulgaria 2
DK - Danimarca 2
EU - Europa 2
NG - Nigeria 2
PK - Pakistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AT - Austria 1
CI - Costa d'Avorio 1
CL - Cile 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
GR - Grecia 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
KZ - Kazakistan 1
ME - Montenegro 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
ZA - Sudafrica 1
Totale 5.301
Città #
Chandler 406
Jacksonville 157
Warsaw 142
Ashburn 128
San Mateo 116
Dublin 109
Nanjing 106
Wilmington 84
Woodbridge 69
Ann Arbor 68
New York 68
Izmir 62
Houston 61
Fairfield 58
Dearborn 57
Beijing 48
Lawrence 45
Redmond 43
Boston 41
Seattle 41
Cattolica 37
Singapore 36
Moscow 31
Bremen 27
Chicago 25
Mountain View 25
Redwood City 23
Cambridge 22
Kunming 21
Nürnberg 20
Shanghai 20
Boardman 19
Detroit 18
Helsinki 18
Nanchang 18
Princeton 18
Shenyang 17
Zhengzhou 17
Hangzhou 16
Milan 16
Rome 16
Hebei 15
Lancaster 13
University Park 13
Brussels 12
Marseille 12
Philadelphia 12
Jiaxing 11
Changsha 9
Pune 9
Tianjin 9
Edinburgh 8
Guangzhou 8
Los Angeles 8
Hefei 7
Lanzhou 7
Simi Valley 7
Toronto 7
Indiana 6
Madrid 6
Norwalk 6
Renton 6
San Jose 6
Centrale 5
Seoul 5
Augusta 4
Hong Kong 4
Istanbul 4
Lansing 4
Littleton 4
Xian 4
Zurich 4
Bern 3
Brea 3
Busto Arsizio 3
Changchun 3
Ciampino 3
Erlangen 3
Falls Church 3
Fremont 3
Guidonia 3
Hanoi 3
Kish 3
Leawood 3
Lindewitt 3
Medan 3
Menlo Park 3
Minsk 3
Monza 3
Najaf 3
Phoenix 3
Salé 3
San Francisco 3
Sivas 3
Timisoara 3
Vigo 3
Amsterdam 2
Ancona 2
Apo 2
Atsugi 2
Totale 2.684
Nome #
FUNCTIONAL ALTERATIONS IN ADULT AND FETAL HEMOGLOBIN SASSARI ASP-ALPHA-126(H9) -] HIS - THE ROLE OF ALPHA(1)ALPHA(2) CONTACT 554
The multikinase inhibitor Sorafenib enhances glycolysis and synergizes with glycolysis blockade for cancer cell killing 330
Neuron-Specific Enolase as a Biomarker: Biochemical and Clinical Aspects 143
Advances in Cancer Biomarkers - From biochemistry to clinic for a critical revision 137
Advances in Cancer Stem Cell Biology 120
CA 19-9: Biochemical and Clinical Aspects 115
3-(4-Aroyl-1-methyl-1H-pyrrol-2-yl)-N-hydroxy-2-propenamides as a New Class of Synthetic Histone Deacetylase Inhibitors. 3. Discovery of Novel Lead Compounds Through Structure-Based Drug Design and Docking Studies 111
MITOCHONDRIAL DAMAGE AND METABOLIC COMPENSATORY MECHANISMS INDUCED BY HYPEROXIA IN U-937 CELL LINE. 110
Mitochondria, ciglitazone and liver: a neglected interaction in biochemical pharmacology. 103
Derangement of erythrocytic AE1 in beta-thalassemia by caspase 3: pathogenic mechanisms and implications in red blood cell senescence 101
Neuron Specific Enolase as a biomarker: biochemical and clinical aspects 101
An update on pharmacological approaches to neurodegenerative diseases. 100
A proteomic approach to characterizing ciglitazone-induced cancer cell differentiation in Hep-G2 cell line 98
A Critical Approach to Clinical Biochemistry of Chromogranin A 98
Prognostic value of the reactive oxygen species in severe sepsis and septic shock patients: a-pilot study 91
3-(4-Aroyl-1-methyl-1H-2-pyrrolyl)-N-hydroxy-2-propenamides as a New Class of Synthetic Histone Deacetylase Inhibitors. 2. Effect of Pyrrole C2 and/or C4 Substitutions on Biological Activity 89
The role of mitochondria in pharmacotoxicology: a reevaluation of an old, newly emerging topic. 88
A two-dimensional electrophoresis preliminary approach to human hepatocarcinoma differentiation induced by PPAR-agonists. 88
Mitochondrial proteomic approaches for new potential diagnostic and prognostic biomarkers in cancer 88
The Role of CA 125 as Tumor Marker: Biochemical and Clinical Aspects 88
The epithelial–mesenchymal transition in cancer: a potential critical topic for translational proteomic research 87
Bezafibrate Induces a Mitochondrial Derangement in Human Cell Lines. Intriguing Effects for a Peroxisome Proliferator. 82
Advances in Mitochondrial Medicine 81
Circulating tumour cells and cancer stem cells: A role for proteomics in defining the interrelationships between function,phenotype and differentiation with potential clinical applications. 81
Modulation of cancer cell line differentiation: A neglected proteomic analysis with potential implications in pathophysiology, diagnosis, prognosis, and therapy of cancer. 77
Revisiting the Warburg effect in cancer cells with proteomics. The emergence of new approaches to diagnosis, prognosis and therapy 77
Immunological role of IgG subclasses 77
CA 19-9: Biochemical and Clinical Aspects 77
Nitric oxide donor drugs: an update on pathophysiology and therapeutic potential. 76
Cancer Stem Cells: An Innovative Therapeutic Approach 74
A critical approach to clinical biochemistry of Chromogranin A 74
Oxygen transport by Fetal Bovine Hemoglobin 73
Immunological role of IgG subclasses 71
Mitochondrial respiration and differentiation 70
Cancer Biomarkers: A Status Quo 69
The proteomics of cancer stem cells. Potential clinical applications for innovative research in oncology 66
Proteomic profiling of heat shock proteins: An emerging molecular approach with direct pathophysiological and clinical implications 63
Cancer stem cells: the development of new cancer therapeutics 63
Cancer Stem Cells: Proteomic Approaches for New Potential Diagnostic and Prognostic Biomarkers 63
The role of CA 125 as tumor marker: biochemical and clinical aspects 62
CA 19-9: Biochemical and Clinical Aspects 62
Glycated human hemoglobin (HbA1c): functional characteristics and molecular modeling studies 61
Cellular respiration and dedifferentiation 60
Advances in Heat Shock Proteomics: Towards a Better Understanding of the Physiology and Pathophysiology of Molecular Chaperones. 60
EFFECTS OF GEMFIBROZIL ON THE OXYGEN-TRANSPORT PROPERTIES OF ERYTHROCYTES 59
Binding mode analysis of 3-(4-benzoyl-1-methyl-1H-2-pyrrolyl)-N-hydroxy-2-propenamide: a new synthetic histone deacetylase inhibitor inducing histone hyperacetylation growth inhibition and terminal cell differentiation 57
THE MULTIPLE FUNCTIONS OF HEMOGLOBIN 57
SEPARATION OF REDUCED AND OXIDIZED GLUTATHIONE BY MICELLAR ELECTROKINETIC CAPILLARY CHROMATOGRAPHY 57
Toward the Standardization of Mitochondrial Proteomics: The Italian Mitochondrial Human Proteome Project Initiative 57
Glycolytic enzyme inhibitors in cancer treatment. 56
Pharmacological modulation of nitric oxide release: new pharmacological perspectives, potential benefits and risks. 56
Aroyl-Pyrrolyl Hydroxyamides: influence of pyrrole C4-phenylacetyl substitution on histone deacetilase inhibition 56
Cytotoxicity of a new endodontic filling material 51
Cancer Stem Cells: A Revisitation of the “Anaplasia” Concept. In Advances in Cancer Stem Cell Biology 50
Resveratrol treatment induces redox stress in red blood cells: a possible role of caspase 3 in metabolism and anion transport 50
Aroyl-pyrrolyl hydroxyamides: influence of pyrrole C4-phenylacetyl substitution on histone deacetylase inhibition. 43
The plasma membrane of erythrocytes plays a fundamental role in the transport of oxygen, carbon dioxide and nitric oxide and in the maintenance of the reduced state of the heme iron. 42
PHYSIOLOGICAL RELEVANCE OF THE OVERALL DELTA-H OF OXYGEN BINDING TO FETAL HUMAN HEMOGLOBIN 39
Exploring the connection unit in the HDAC inhibitor pharmacophore model: novel uracil-based hydroxamates. 37
Mitochondria and cancer: a growing role in apoptosis, cancer cell metabolism and dedifferentiation 35
Nitroflurbiprofen (NicOx). 34
Mitochondria and drugs 28
Mitochondria, PPARs, and Cancer: Is Receptor-Independent Action of PPAR Agonists a Key? 28
Totale 5.351
Categoria #
all - tutte 18.054
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.054


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020511 0 62 24 29 19 43 97 35 36 22 72 72
2020/2021594 46 68 13 63 75 53 61 5 81 18 97 14
2021/2022567 48 69 9 59 32 24 14 91 17 26 73 105
2022/20231.663 154 191 94 169 94 137 29 118 583 26 52 16
2023/2024458 25 142 5 12 19 75 16 22 5 23 63 51
2024/202538 34 4 0 0 0 0 0 0 0 0 0 0
Totale 5.351